MyOme - Benefits Consultants

Differentiate Your Benefits Strategy with Preventive Genomics

We partner with benefits consultants to bring genomic health screening to employer benefit programs, guaranteed to deliver strong employee engagement, actionable health insights, and long-term healthcare savings through earlier intervention, personalized care, and lifelong genomic insights.

Genomic Risk Insights Reduce Healthcare Spend

Many of the most expensive healthcare claims stem from conditions that can be identified and addressed earlier. MyOme's Proactive Health tests uncover disease risk and medication response insights before conditions progress or medication-related events occur, enabling more proactive care, lower-cost interventions, and more effective prescribing. The result is a tangible strategy for helping clients stay ahead of rising healthcare and pharmacy costs.

Reduce Cancer Treatment Costs

Single-Gene Risk insights for cancers, including breast cancer, can stimulate early screening, detection, and treatment. Treating breast cancer early can reduce treatment costs by >$500K.¹

>$500K

Cut Heart Disease Spend

Polygenic Risk Scores for Coronary Artery Disease (CAD) can lead to early interventions—like statin therapy—that reduce heart event risk and avoid $40K in annual treatment costs.²

~$40K

Avoid
Hospitalizations

Medication Response insights enable safe prescribing from the start. This type of screening is proven to reduce medication-related ER visits and inpatient stays by ~40%.³

~40%

Reddy SR, Chung KC, Kansal AR, et al. Current Medical Research and Opinion. 2022; 38(5):791-800. doi: 10.1080/03007995.2022.2047536.
Kazi DS, Elkind MSV, Deutsch A, et al. Circulation. 23 Jul 2024; 150(4):e89-e101. doi: 10.1161/CIR.0000000000001258.
Fragala MS, Keogh M, Goldberg SE, Lorenz RA, and Shaman JA. The Pharmacogenomics Journal. 2 Oct 2024; 24(5):30. doi: 10.1038/s41397-024-00350-1.

Continuous Value Beyond Initial Testing

A single genomic test delivers lifelong value. By transforming whole-genome data into a continuously updated resource, MyOme helps uncover new health insights that continue to drive better care and healthcare savings year after year.

Positive net savings in first year

Significant net savings start in second year

Net savings continue to compound

*Modeled data for an active employer program.

Employee Participation

44%

of employees engaged in the program within 90-days of access to MyOme testing

Disease Risk Detection

~14%

of employees tested carried at least one clinically significant, high-impact risk variant linked to a health condition

High-Risk Classification

~20%

of employees were identified as high-risk for cardiometabolic disease or cancer

*Results averaged across active employer programs.

More than 50% of cancers and up to 80% of cardiac diseases are preventable. By integrating genomics into employer health programs, we provide participants with knowledge that can save lives and significantly improve outcomes.

Patient support and privacy

We provide patients with support to fully understand their results, including access to genetic counselors for guidance on preventive strategies. We also ensure that personal data is encrypted and never shared without patient consent.

Privacy and Security

Get in touch to find the right program

We want to help find the right program for employers and their employees to benefit from MyOme's tests. Contact us to find out how MyOme can enhance your organization's health benefit offerings.